Ken Griffin’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-106,899
Closed -$738K 7380
2025
Q1
$738K Buy
106,899
+80,284
+302% +$554K ﹤0.01% 3600
2024
Q4
$141K Buy
26,615
+26,313
+8,713% +$140K ﹤0.01% 5040
2024
Q3
$1.1K Sell
302
-9,650
-97% -$35.2K ﹤0.01% 5619
2024
Q2
$27.2K Sell
9,952
-31,081
-76% -$84.9K ﹤0.01% 5337
2024
Q1
$143K Sell
41,033
-138,662
-77% -$483K ﹤0.01% 4936
2023
Q4
$257K Buy
179,695
+6,925
+4% +$9.9K ﹤0.01% 4380
2023
Q3
$252K Sell
172,770
-14,443
-8% -$21.1K ﹤0.01% 4391
2023
Q2
$294K Sell
187,213
-22,779
-11% -$35.8K ﹤0.01% 4131
2023
Q1
$321K Buy
209,992
+59,701
+40% +$91.3K ﹤0.01% 4245
2022
Q4
$252K Buy
150,291
+93,726
+166% +$157K ﹤0.01% 4493
2022
Q3
$70K Sell
56,565
-316,992
-85% -$392K ﹤0.01% 5217
2022
Q2
$623K Buy
373,557
+264,478
+242% +$441K ﹤0.01% 3927
2022
Q1
$268K Sell
109,079
-38,144
-26% -$93.7K ﹤0.01% 5040
2021
Q4
$551K Buy
147,223
+112,257
+321% +$420K ﹤0.01% 4489
2021
Q3
$219K Buy
34,966
+5,740
+20% +$36K ﹤0.01% 5339
2021
Q2
$288K Sell
29,226
-44,081
-60% -$434K ﹤0.01% 5256
2021
Q1
$685K Buy
+73,307
New +$685K ﹤0.01% 4290
2020
Q3
Sell
-29,704
Closed -$137K 5383
2020
Q2
$137K Sell
29,704
-43,751
-60% -$202K ﹤0.01% 4177
2020
Q1
$239K Buy
+73,455
New +$239K ﹤0.01% 3958
2019
Q1
Sell
-21,050
Closed -$72K 5121
2018
Q4
$72K Sell
21,050
-23,286
-53% -$79.6K ﹤0.01% 4065
2018
Q3
$190K Buy
44,336
+27,315
+160% +$117K ﹤0.01% 3762
2018
Q2
$63K Sell
17,021
-42,319
-71% -$157K ﹤0.01% 3887
2018
Q1
$249K Buy
+59,340
New +$249K ﹤0.01% 3350